Other interesting reports have shown that in vivo neutralization of IL-21 can lead to decreased rheumatoid arthritis in rats and lupus development in mice, as well inhibition of matrix metalloproteinase secretion in inflammatory bowel disease (18, 52, 57). Here, IL21 is linked to systemic lupus erythematosus.